Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 4
Submit an article Journal homepage
314
Views
9
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma

Edward G. BrooksFaculty of Medicine, University of British Columbia, Vancouver, BC, Canada,
,
Joseph M. ConnorsCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada, and
,
Laurie H. SehnCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada, and
,
Randy D. GascoyneCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada, and
,
Kerry J. SavageCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada, and
,
Tamara N. ShenkierCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada, and
,
Richard KlasaCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada, and
,
Alina S. GerrieCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada, and ;Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, BC, Canada
,
Brian SkinniderCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada, and
,
Graham W. SlackCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada, and
&
Diego VillaCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada, and Correspondence[email protected]
 show all
Pages 872-879 | Received 03 Jul 2015, Accepted 20 Aug 2015, Published online: 13 Oct 2015

References

  • Swerdlow SH, Campo E, Harris NL, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissue. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008.
  • Canellos GP, Niedzwiecki D, Johnson JL. Long-term follow-up of survival in Hodgkin’s lymphoma. N Engl J Med 2009;361:2390–2391.
  • Viviani S, Zinzani PL, Rambaldi A, et al. ABVD versus BEACOPP for Hodgkin’s lymphoma when high-dose salvage is planned. N Engl J Med 2011;365:203–212.
  • Engert A, Diehl V, Franklin J, et al. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin’s lymphoma: 10 years of follow-up of the GHSG HD9 study. J Clin Oncol 2009;27:4548–4554.
  • Meyer RM, Gospodarowicz MK, Connors JM, et al. ABVD alone versus radiation-based therapy in limited-stage Hodgkin’s lymphoma. N Engl J Med 2012;366:399–408.
  • Hoskin PJ, Lowry L, Horwich A, et al. Randomized comparison of the Stanford V regimen and ABVD in the treatment of advanced Hodgkin’s Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. J Clin Oncol 2009;27:5390–5396.
  • Bonadonna G, Zucali R, Monfardini S, et al. Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 1975;36:252–259.
  • DeVita VT, Jr, Simon RM, Hubbard SM, et al. Curability of advanced Hodgkin’s disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med 1980;92:587–595.
  • Lohrisch C, Paltiel C, Gelmon K, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 2006;24:4888–4894.
  • Gagliato Dde M, Gonzalez-Angulo AM, Lei X, et al. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol 2014;32:735–744.
  • Hershman D, Hall MJ, Wang X, et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer 2006;107:2581–2588.
  • Cheung WY, Neville BA, Earle CC. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer. Dis Colon Rectum 2009;52:1054–1063; discussion 1064.
  • Biagi JJ, Raphael MJ, Mackillop WJ, et al. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA 2011;305:2335–2342.
  • Xing KH, Connors JM, Lai A, et al. Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis. Blood 2014;123:3567–3573.
  • Nogova L, Reineke T, Brillant C, et al. Lymphocyte-predominant and classical Hodgkin’s lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol 2008;26:434–439.
  • Hartmann S, Eichenauer DA, Plutschow A, et al. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood 2013;122:4246–4252; quiz 4292.
  • Du Plessis V, Beshiri, R, Bollman, R, et al. Definitions of ‘Rural’. Ottawa, Canada: Agric Rural Work 2002; 2015(Working Paper No. 61).
  • Lee B, Goktepe O, Hay K, et al. Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British Columbia. Oncologist 2014;19:283–290.
  • Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Statistical Ass 1958;53:457–481.
  • Eichenauer DA, Engert A, Andre M, et al. Hodgkin’s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014;25(Suppl. 3):iii70–75.
  • Hay K, Lee B, Goktepe O, et al. Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma. Leuk Lymphoma 2015. [Epub ahead of print]. doi: 10.3109/10428194.2015.1055480.
  • Nikonova A, Guirguis HR, Buckstein R, et al. Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survival. Br J Haematol 2015;168:492–500.
  • Booth CM, Shepherd FA, Peng Y, et al. Time to adjuvant chemotherapy and survival in non-small cell lung cancer: a population-based study. Cancer 2013;119:1243–1250.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.